Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT00163865 Completed - Anxiety Disorders Clinical Trials

A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents

Start date: May 2005
Phase: N/A
Study type: Observational

The aim of the following pilot study is to examine boredom in a community sample of adolescents and a clinical sample of adolescents. This is important in order to examine differences among healthy adolescents and adolescents with mental illness.

NCT ID: NCT00159965 Completed - Depression Clinical Trials

Treatments for Psychogenic Nonepileptic Seizures (NES)

NES
Start date: December 2003
Phase: Phase 4
Study type: Interventional

The investigators propose that treatment of the comorbid disorders (depression, anxiety, and impulsivity) with sertraline in patients with lone psychogenic nonepileptic seizures (NES), will result in a decreased number of NES. The purpose of this study is to provide pilot testing and data to inform the future randomized controlled trial based on the hypothesis.

NCT ID: NCT00159770 Completed - Schizophrenia Clinical Trials

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Start date: November 2001
Phase: Phase 3
Study type: Interventional

Evaluation of the antipsychotic efficacy and safety of ziprasidone versus olanzapine, risperidone or quetiapine in patients with schizophrenia, schizoaffective and schizophreniform disorders under naturalistic conditions of clinical practice

NCT ID: NCT00158327 Completed - Anxiety Disorders Clinical Trials

Telephone-Based Care Management Program for Individuals With Anxiety Disorders

Start date: March 2004
Phase: Phase 3
Study type: Interventional

This study will determine the impact of a telephone-based care management program for primary care patients with panic disorder or generalized anxiety disorder.

NCT ID: NCT00158262 Completed - Clinical trials for Post-Traumatic Stress Disorder

Effect of Propranolol on Preventing Posttraumatic Stress Disorder

Start date: September 2004
Phase: Phase 4
Study type: Interventional

This study will assess the effectiveness of taking propranolol soon after a traumatizing incident in reducing the incidence and severity of posttraumatic stress disorder in acutely traumatized individuals.

NCT ID: NCT00158184 Completed - Clinical trials for Substance-Related Disorders

Prescription Opioid Effects in Abusers Versus Non-Abusers

Start date: June 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine the abuse liability of oxycodone and codeine in individuals with, and without, a history of prescription opioid abuse. The subjective and reinforcing effects of each drug will also be examined in the presence, and absence, of experimentally induced pain.

NCT ID: NCT00158028 Completed - Clinical trials for Schizotypal Personality Disorder

Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder

Start date: November 1995
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of risperidone compared to placebo in the treatment of the psychotic-like and deficit symptoms of schizotypal personality disorder (SPD). Treatment with risperidone, a 5HT2 and dopamine D2 blocking agent, holds particular promise in the treatment of SPD. Unlike traditional antipsychotics, risperidone targets the deficit or negative symptoms of schizophrenia. The deficit-like symptoms of SPD are therefore also likely respond to treatment with risperidone. One common complication in the present psychopharmacologic treatment of SPD with traditional neuroleptics is the fact that many patients discontinue treatment due to the medication-induced dysphoria. Given initial reports and the serotonergic component of the risperidone mechanism, risperidone is anticipated to produce little or no dysphoria.

NCT ID: NCT00156715 Completed - Schizophrenia Clinical Trials

Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder

Start date: March 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine the efficacy of quetiapine (Seroquel) in reducing substance use in persons diagnosed with schizophrenia. The primary hypothesis is that quetiapine treatment will be associated with a decrease in substance use.

NCT ID: NCT00156221 Completed - Autism Clinical Trials

MR Scanning of Very Young Children With Severe Developmental Disorders

Start date: September 2000
Phase: N/A
Study type: Observational

The specific is to study the MR morphologic and spectroscopic brain correlates and predictors of development in children with severe developmental disorders (autistic spectrum disorders and/or mental retardation and/or language disorders). Given the frequently observed association of autism with known medical conditions, particularly in cases with comorbid mental retardation and in cases with atypical autism (Rutter et al., 1994; Gillberg, 1995), children with suspected autism or related developmental disorders will be asked to participate in an extensive state of the art laboratory work-up which includes T1 and T2 weighted MRI of the brain. MRI data will be analyzed both qualitatively, looking for focal abnormalities and degree of myelination, and quantitatively, measuring volumes of total brain, cerebellum, ventricles and grey and white matter. For research purposes, the work-up will be supplied with proton Magnetic Resonance Spectroscopy (MRS) of the brain. This data set provides the opportunity to chart brain-behavior relationships in young children with suspected autism and related PDD cross-sectionally.

NCT ID: NCT00154128 Completed - Chronic Disease Clinical Trials

The Influence of a Stabilization Splint on the Body Posture

Start date: April 2005
Phase: Phase 1
Study type: Interventional

The study was designed to investigate a possible influence of an occlusal stabilization splint on the body posture in TMD cases and controls. Interocclusal appliances or occlusal splints are therapeutic devices that are most frequently used in the treatment of TMD. Changes of the mandibular position and occlusal equilibrations are assumed to have an impact on the general body posture.